of the cytokine, the antigenic domain, and their interaction, particularly in regard to mechanisms of APC conditioning, antigenic targeting, and early biasing of T cell subsets may be the key considerations of antigen-specific tolerogenic efficacy.Because a substantial percentage of all cytokine-NAg vaccines tested in the rat model had significant tolerogenic efficacy, the extrapolation is that ma